Prognostic Indicators and Clinical Characteristics of Brain Metastases in Ovarian Cancer: A Retrospective Analysis of 129 Cases Across Multiple Centers - Takeaways - MDSpire

Prognostic Indicators and Clinical Characteristics of Brain Metastases in Ovarian Cancer: A Retrospective Analysis of 129 Cases Across Multiple Centers

  • By

  • Yingying Wang

  • Qiyue Chao

  • Xiaoyan Lu

  • Yichi Zhou

  • Zhiwen Xie

  • Shiyun Zhang

  • Fei Xu

  • Sikao Wu

  • Lvzhong Hu

  • Bo Ding

  • Xinyi Zhang

  • Tianmin Xu

  • Guantai Ni

  • Jing Liang

  • Jinhua Zhou

  • Yang Shen

  • Bo Yang

  • Shengtao Zhou

  • Xiaojun Chen

  • Tingyan Shi

  • Chunyan Lan

  • Tao Zhu

  • Ying Zhou

  • November 7, 2025

  • 0 min

Share

  • 1

    Brain metastases occur in 2.5%-6.0% of ovarian cancer patients, with a 5-year overall survival rate of only 29.2%.

  • 2

    The study analyzed 129 ovarian cancer patients with brain metastases across 12 Chinese institutions from 2010 to 2022.

  • 3

    Independent predictors of poor prognosis include high serum CA-125 levels, multiple brain metastases, and headache attributed to brain metastases.

  • 4

    Patients diagnosed with brain metastases during second-line or later relapse showed better overall survival compared to those diagnosed earlier.

  • 5

    The study highlights the need for standardized treatment protocols for brain metastases in ovarian cancer to improve patient management.

Original Source(s)

Related Content